REQUEST A DEMO
Total
USD $0.00
Search more companies

U2Bio (Thailand) Company Limited (Thailand)

Main Activities: General Medical and Surgical Hospitals
Full name: U2Bio (Thailand) Company Limited Profile Updated: August 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

U2Bio (Thailand) Company Limited is based in Thailand. The head office is in Bangkok , Special Governed District of. The enterprise currently operates in the General Medical and Surgical Hospitals sector. It was incorporated on August 24, 2026. The total number of employees is currently 4 (2024). There was a net sales revenue increase of 20.69% reported in U2Bio (Thailand) Company Limited’s latest financial highlights for 2025. A growth of 20.35% was recorded in its total assets. In, 2025, the company’s net profit margin increased by 0.27%.

Headquarters
1000/77 Rama Iii Road Soi Trok Wat Chan Nai
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10120

Contact Details: Purchase the U2Bio (Thailand) Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the U2Bio (Thailand) Company Limited report to view the information.
Financial Auditors:
Purchase the U2Bio (Thailand) Company Limited report to view the information.
Incorporation Date:
August 24, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after U2Bio (Thailand) Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
20.69%
Total Operating Revenue
20.73%
Operating Profit
14.33%
Net Profit/Loss for the Period
23.86%
Total Assets
20.35%
Total Equity
1231.66%
Operating Profit Margin
-0.79%
Net Profit Margin
0.27%
Return on Equity (ROE)
-901.91%
Debt / Equity
-569.14%
Quick Ratio
0.29%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?